Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Rani Therapeutics Holdings, Inc. (RANI) had Return on Tangible Equity of 66.10% for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-5.41M |
|
-- |
|
-- |
|
$7.26M |
|
$-7.26M |
|
$-0.66M |
|
$-7.91M |
|
$-7.91M |
|
$-7.91M |
|
$-7.91M |
|
$-7.91M |
|
$-7.91M |
|
$-7.26M |
|
$-6.98M |
|
46.44M |
|
46.44M |
|
$-0.12 |
|
$-0.12 |
|
| Balance Sheet Financials | |
$4.96M |
|
$0.92M |
|
$5.18M |
|
$10.14M |
|
$19.14M |
|
-- |
|
$2.97M |
|
$22.11M |
|
$-11.97M |
|
$-11.97M |
|
$-11.97M |
|
71.91M |
|
| Cash Flow Statement Financials | |
$-19.01M |
|
$23.94M |
|
$-4.55M |
|
$4.26M |
|
$4.64M |
|
$0.38M |
|
$9.56M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.26 |
|
-- |
|
-- |
|
-- |
|
-1.13 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-19.10M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
66.10% |
|
|
Return on Tangible Equity |
66.10% |
-78.06% |
|
66.10% |
|
$-0.17 |
|
$-0.41 |
|
$-0.41 |
|